Navidea eyes Europe for Lymphoseek

06/30/2013 | American City Business Journals

Navidea Biopharmaceuticals is working to secure European approval for its imaging agent Lymphoseek by the end of 2013. The company also said it has chosen a "specialty pharmaceutical company" as a potential distribution partner for Europe. Company President and Chief Business Officer Thom Tulip said Navidea is aiming to develop Lymphoseek for additional cancers.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
European Sales Manager
SentreHEART, Inc.
Germany, Benelux, UK
REG AFFAIRS PROJ MGR - 1400000A7F
Abbott
San Jose, CA
SPECIALIST II SYSTEMS INTEGRATION - 140000033P
Abbott
Dallas, TX
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD